rebel Financial rebel Financial
← All Posts
IMNM

Immunome, Inc.

June 10, 2026 • Author: Phil Ratcliff • IMNM
Item Proposal Vote
1 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal.
1a James Boylan ✓ For
1b Sandra M. Swain, M.D. ✓ For
1c Philip Wagenheim ✓ For
2 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. ✓ For
3 To approve, on an advisory basis, the compensation of our named executive officers. ✓ For
4 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. 1 Year
Attachments
📄
IMNM_ANNUAL_REPORT_2025.pdf 2.9 MB
📄
IMNM_PROXY_STATEMENT.pdf 0.8 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.